Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro KwikPen uses a fixed, integrated needle that is 4 mm long and 32 gauge — one of the shortest, finest needles used in any weight-loss injection available in the UK. You don't attach or remove it yourself; it's built into the pen's cap mechanism and automatically covered after the injection completes. These specifics come from the Mounjaro SmPC and Patient Information Leaflet on the eMC, and they matter more than many people realise before their first dose. Mounjaro is a prescription-only medicine, so a clinical assessment by a registered prescriber comes before any treatment — but understanding the pen's mechanics makes starting feel considerably less daunting.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC (the formal prescribing document lodged with the MHRA) specifies a 4 mm, 32 gauge integrated needle. That combination sits at the fine end of subcutaneous injection practice globally. To put it in everyday terms: 32 gauge is thinner than the needles used for most routine blood tests, and 4 mm is roughly the depth of a thick fingernail. The clinical rationale is straightforward: tirzepatide needs to reach the fatty tissue just below the skin, not the muscle beneath it. A shorter, finer needle achieves that reliably across a broad range of body types, and it reduces the discomfort that put many people off self-injection in the first place.
The NHS tirzepatide medicines page notes that injection-site reactions are among the possible side effects (redness, mild swelling, bruising) and correct needle placement is one of the factors that keeps these to a minimum. The SmPC is the authoritative reference for storage, administration steps and what to do if something looks wrong; our guide to the Mounjaro injection process covers the practical sequence in more detail.
When your Mounjaro pen is dispatched, it reaches you via DPD tracked delivery in plain, unbranded packaging, no indication of what's inside. Inside the box you'll find the KwikPen itself: a pre-filled device containing four weekly doses. The needle is already integrated; there's nothing to screw on or attach before your first injection, and nothing to remove and dispose of separately afterwards. Once you complete an injection and withdraw the pen, the outer needle shield automatically advances to cover the tip and locks in place. That single-step safety feature removes a practical worry for people new to self-injection.
Because the needle is integrated, you don't need to source replacements between doses in the same way you might with a conventional injection device. If you have questions about what compatible accessories look like for any reason, our overview of the Mounjaro pen and needle setup explains what's included and what isn't. Sharps disposal still applies after each pen is finished; a 1-litre sharps container is a practical item to have at home before you start.
The three licensed injection sites for Mounjaro are the abdomen, the outer thigh, and the upper arm. Rotating between them (and within them) is a standard instruction because repeated injections at exactly the same spot can cause localised tissue changes over time. At 4 mm, the needle's depth is well-suited to all three sites in most adults; the subcutaneous layer is accessible at each location without the risk of inadvertent intramuscular injection that longer needles would carry, particularly at the upper arm.
Exact technique (pinching the skin, angle of insertion, how long to hold after depressing the button) is set out in the Patient Information Leaflet that arrives with each pen and should be followed precisely. Our page on the injection needle addresses some of the practical questions about angles and site preparation that come up most often. If you're curious about how the needle gauge compares across available sizes, there's a direct comparison of Mounjaro needle sizes that covers the clinical background.
SURMOUNT-1 (the pivotal trial published in the New England Journal of Medicine, involving 2,539 adults with obesity) found that tirzepatide produced around 20–21% average body-weight reduction at the 15 mg dose over 72 weeks. Injection-related discomfort wasn't a primary endpoint, but dropout attributable to injection-site issues was low across arms. The dose escalation schedule (starting at 2.5 mg for the first four weeks to allow the body to adjust) means most people's first several injections happen while the dose is at its gentlest, giving time to build confidence with the pen before moving up.
Understanding the needle's dimensions is one small part of that confidence-building. Many people who've never self-injected expect something much longer; the reality is a needle barely visible once the pen is in position. A question our prescribers hear regularly is whether BMI affects how far the needle penetrates, the answer is that the pen's 4 mm reach is designed with the range of subcutaneous tissue depths in mind, though technique adjustments (such as skin pinch) may vary by body type per the PIL.
Mounjaro is a prescription-only medicine. A clinical assessment covers your health history, any medicines you take, and whether treatment is appropriate, including the important interaction between Mounjaro and hormonal contraception that every patient should know about before starting. If you'd like to understand how treatment through a regulated UK pharmacy works, the consultation is free and reviewed the same day by one of our GPhC-registered prescribers. Cost context is covered on our Mounjaro pricing page for anyone weighing up the private route.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.